Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Haiming Ru"'
Autor:
Maosen Huang, Yancen Wu, Linyao Cheng, Lihua Fu, Haochao Yan, Haiming Ru, Xianwei Mo, Linhai Yan, Zijie Su
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundGlucose metabolic reprogramming (GMR) is a cardinal feature of carcinogenesis and metastasis. However, the underlying mechanisms have not been fully elucidated. The aim of this study was to profile the metabolic signature of primary tumor a
Externí odkaz:
https://doaj.org/article/1cd8cfaf6e8e4dc8be99b15f09d8691b
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveLiver metastasis of colorectal cancer (LMCRC) is a major cause of cancer-related deaths worldwide. We can reduce the mortality rate by discerning the risk of liver metastases in patients with colorectal cancer at an early stage. Hence, we co
Externí odkaz:
https://doaj.org/article/af62cd0047ab4bc6a42db83c45131b14
Autor:
Jungang Liu, Xiaoliang Huang, Haizhou Liu, Chunyin Wei, Haiming Ru, Haiquan Qin, Hao Lai, Yongsheng Meng, Guo Wu, Weishun Xie, Xianwei Mo, Caroline H. Johnson, Yawei Zhang, Weizhong Tang
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-17 (2021)
Abstract Background KRAS gene is the most common type of mutation reported in colorectal cancer (CRC). KRAS mutation-mediated regulation of immunophenotype and immune pathways in CRC remains to be elucidated. Methods 535 CRC patients were used to com
Externí odkaz:
https://doaj.org/article/a598a506abff49d59c9171407e1c1ec1
Autor:
Weishun Xie MS, Xiaoliang Huang MS, Chunyin Wei MD, Xianwei Mo MD, Haiming Ru MS, Lihua Zhang BS, Lianying Ge MD, Weizhong Tang MD, Jungang Liu MD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 21 (2022)
Background: Inflammation and nutritional status are highly associated with colorectal cancer (CRC) prognosis. This study aimed to evaluate the prognostic value of the preoperative neutrophil-BMI ratio (NBR) in patients with CRC. Methods: A retrospect
Externí odkaz:
https://doaj.org/article/53d256928fbe4c9e9994462b198813c5
Autor:
Xianwei Mo, Xiaoliang Huang, Yan Feng, Chunyin Wei, Haizhou Liu, Haiming Ru, Haiquan Qin, Hao Lai, Guo Wu, Weishun Xie, Franco Jeen, Yuan Lin, Jungang Liu, Weizhong Tang
Publikováno v:
OncoImmunology, Vol 9, Iss 1 (2020)
Fluoropyrimidine-based chemotherapy is an essential component of systemic chemotherapy for colorectal cancer (CRC). The immune response is implicated in chemotherapy-induced cytotoxicity. Here, we reported an immune risk (Imm-R) model for prognostic
Externí odkaz:
https://doaj.org/article/3eadb590a77b496680bb5fb3d2a87321
Autor:
Huang, Maosen, Yancen Wu, Linyao Cheng, Lihua Fu, Haochao Yan, Haiming Ru, Xianwei Mo, Linhai Yan, Zijie Su
Publikováno v:
Frontiers in Immunology; 2023, p1-14, 14p
Objective: Circular RNAs (circRNAs), a specific type of non-coding RNAs, could regulate tumorigenesis and metastasis of various cancers though acting as competing endogenous RNA (ceRNAs).Methods: Performing next generation sequencing (NGS) and bioinf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c98a379671666b5607f38876c85fb1d2
https://doi.org/10.21203/rs.3.rs-1500197/v1
https://doi.org/10.21203/rs.3.rs-1500197/v1
Publikováno v:
Journal of inflammation research. 15
It is widely recognized that microbial disorders are involved in the pathogenesis of many malignant tumors. The oral and intestinal tract are two of the overriding microbial habitats in the human body. Although they are anatomically and physiological
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b6eb4a345680ff90cc174f28ba97318
https://pubmed.ncbi.nlm.nih.gov/35153499
https://pubmed.ncbi.nlm.nih.gov/35153499
Autor:
Yongsheng Meng, Chunyin Wei, Guo Wu, Xiaoliang Huang, Hao Lai, Haizhou Liu, Haiquan Qin, Weizhong Tang, Yawei Zhang, Caroline H. Johnson, Haiming Ru, Xianwei Mo, Jungang Liu, Weishun Xie
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-17 (2021)
Journal of Translational Medicine
Journal of Translational Medicine
Background KRAS gene is the most common type of mutation reported in colorectal cancer (CRC). KRAS mutation-mediated regulation of immunophenotype and immune pathways in CRC remains to be elucidated. Methods 535 CRC patients were used to compare the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::710ad4ceeef960c6ba9f7a78ef0fef5e
https://doi.org/10.1186/s12967-020-02638-9
https://doi.org/10.1186/s12967-020-02638-9
Autor:
Jungang Liu, Xiaoliang Huang, Haizhou Liu, Chunyin Wei, Haiming Ru, Haiquan Qin, Lai, Hao, Yongsheng Meng, Wu, Guo, Weishun Xie, Xianwei Mo, Johnson, Caroline H., Yawei Zhang, Weizhong Tang
Additional file 9: Table S1. Multivariate analyses of prognostic tumor-infiltrating immune cells in patients with KRAS-mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61d3a8bbcb8217ddfb6bfd60c3f20e2c